Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA

Infection and Immunity

Volumn 79, Issue 10, 2011, Pages 3947-3956

  Tamura, Takahiko ^a,b   Kimura, Kazumi ^a   Yuda, Masao ^c   Yui, Katsuyuki ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; FLT3 LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANZYME B; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ERYTHROCYTE; GRANULOCYTE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HUMANS; MALARIA, CEREBRAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASITEMIA; PLASMIDS; PLASMODIUM BERGHEI;

EID: 80855164911     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01337-10     Document Type: Article

References (40)

1. Baptista, F. G., et al. 2010. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 78:4033-4039.
2. Belnoue, E., et al. 2003. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 101:4253-4259.
3. + T cells in experimental cerebral malaria. J. Immunol. 169:6369-6375.
4. Beyer, M., et al. 2005. The β2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo. Respir. Res. 6:70.
5. Bullard, D. C., X. Hu, J. E. Adams, T. R. Schoeb, and S. R. Barnum. 2007. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. Am. J. Pathol. 170:2001-2008.
6. Campanella, G. S., et al. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. U. S. A. 105:4814-4819.
7. Chen, L., Z. Zhang, and F. Sendo. 2000. Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clin. Exp. Immunol. 120:125-133.
8. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
9. de Souza, J. B., J. C. Hafalla, E. M. Riley, and K. N. Couper. 2009. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137:755-772.
10. deWalick, S., et al. 2007. Conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 178:6033-6037.
11. Fleming, T. J., M. L. Fleming, and T. R. Malek. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:2399-2408.
12. Herweijer, H., and J. A. Wolff. 2007. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther. 14:99-107.
13. + T cells in vivo. J. Immunol. 154:5684-5693.
14. Idro, R., N. E. Jenkins, and C. R. Newton. 2005. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4:827-840.
15. Ing, R., M. Segura, N. Thawani, M. Tam, and M. M. Stevenson. 2006. Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J. Immunol. 176:441-450.
16. + dendritic cells in vivo. J. Exp. Med. 198:305-313.
17. Langhorne, J., et al. 2004. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol. Rev. 201:35-47.
18. + T cells following an acute virus infection. Eur. J. Immunol. 33:2736-2743.
19. + dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 105:14509-14514.
20. Lundie, R. J., et al. 2010. Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells. Eur. J. Immunol. 40:1674-1681.
21. Maraskovsky, E., et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1962.
22. McKenna, H. J., et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489-3497.
23. Miller, G., V. G. Pillarisetty, A. B. Shah, S. Lahrs, and R. P. DeMatteo. 2003. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J. Immunol. 170:3554-3564.
24. Miu, J., et al. 2008. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 180:1217-1230.
25. + T cells during blood stage of Plasmodium berghei infection. J. Immunol. 181:1420-1428.
26. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170:2221-2228.
27. H2 and tolerogenic responses. Nat. Immunol. 11:647-655.
28. Sadhu, C., et al. 2007. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. J. Leukoc. Biol. 81:1395-1403.
29. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5:722-735.
30. Senaldi, G., C. Vesin, R. Chang, G. E. Grau, and P. F. Piguet. 1994. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect. Immun. 62:1144-1149.
31. Shinkai, Y., et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
32. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:19-30.
33. Sponaas, A. M., et al. 2006. Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J. Exp. Med. 203:1427-1433.
34. Sponaas, A. M., et al. 2009. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 114:5522-5531.
35. Swee, L. K., N. Bosco, B. Malissen, R. Ceredig, and A. Rolink. 2009. Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood 113:6277-6287.
36. Taylor, T. E., et al. 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10:143-145.
37. Van den Steen, P. E., et al. 2008. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-γ-induced chemokines. Eur. J. Immunol. 38:1082-1095.
38. Waskow, C., et al. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9:676-683.
39. Wykes, M. N., et al. 2007. Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog. 3:e96.
40. Yanez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1620-1624.